Side-by-side financials for FENC and GILD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FENC | GILD |
|---|---|---|
| Market cap | - | $155.93 B |
| US-listed rank | - | #98 |
| Revenue (latest FY) | $44.64M | $29.44B |
| Net income (latest FY) | -$9.74B | $8.51B |
| Net margin | -21820.3% | 28.9% |
| P/E (trailing FY) | - | 18.3 |
| SEC filings | 792 | 981 |
In their latest fiscal years, FENNEC PHARMACEUTICALS INC. reported $44.64M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: FENNEC PHARMACEUTICALS INC. and GILEAD SCIENCES, INC., or browse the full rankings.